“Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid”, Bangladesh J of Otorhinolaryngology, vol. 31, no. 2, pp. 86–94, Apr. 2026, doi: 10.3329/bjo.v31i2.89000.